Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126482531 | 12648253 | 1 | I | 20160804 | 20160812 | 20160812 | EXP | CA-APOTEX-2016AP010381 | APOTEX | 67.00 | YR | M | Y | 0.00000 | 20160812 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126482531 | 12648253 | 1 | PS | APO-AZITHROMYCIN | AZITHROMYCIN ANHYDROUS | 1 | Oral | 250 MG, BID | U | U | 65507 | 250 | MG | TABLET | BID | ||||
| 126482531 | 12648253 | 2 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 20 MG, UNK | U | U | 0 | 20 | MG | TABLET | |||||
| 126482531 | 12648253 | 3 | SS | SEEBRI BREEZHALER | GLYCOPYRROLATE | 1 | Respiratory (inhalation) | 50 MG, ONCE DAILY | U | U | 0 | 50 | MG | CAPSULE | |||||
| 126482531 | 12648253 | 4 | C | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Unknown | U | U | 0 | |||||||||
| 126482531 | 12648253 | 5 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Unknown | U | U | 0 | |||||||||
| 126482531 | 12648253 | 6 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | Unknown | U | U | 0 | CAPSULE | ||||||||
| 126482531 | 12648253 | 7 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Unknown | U | U | 0 | |||||||||
| 126482531 | 12648253 | 8 | C | PULMICORT TURBUHALER | BUDESONIDE | 1 | Unknown | U | U | 0 | |||||||||
| 126482531 | 12648253 | 9 | C | QVAR | BECLOMETHASONE DIPROPIONATE | 1 | Unknown | U | U | 0 | |||||||||
| 126482531 | 12648253 | 10 | C | REMICADE | INFLIXIMAB | 1 | Unknown | U | U | 0 | |||||||||
| 126482531 | 12648253 | 11 | C | SALBUTAMOL | ALBUTEROL | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126482531 | 12648253 | 1 | Product used for unknown indication |
| 126482531 | 12648253 | 2 | Blood cholesterol increased |
| 126482531 | 12648253 | 3 | Asthma |
| 126482531 | 12648253 | 4 | Product used for unknown indication |
| 126482531 | 12648253 | 5 | Product used for unknown indication |
| 126482531 | 12648253 | 6 | Product used for unknown indication |
| 126482531 | 12648253 | 7 | Product used for unknown indication |
| 126482531 | 12648253 | 8 | Product used for unknown indication |
| 126482531 | 12648253 | 9 | Product used for unknown indication |
| 126482531 | 12648253 | 10 | Product used for unknown indication |
| 126482531 | 12648253 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126482531 | 12648253 | HO |
| 126482531 | 12648253 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126482531 | 12648253 | Asthma | |
| 126482531 | 12648253 | Blood immunoglobulin E increased | |
| 126482531 | 12648253 | Dyspnoea | |
| 126482531 | 12648253 | Dyspnoea at rest | |
| 126482531 | 12648253 | Dyspnoea exertional | |
| 126482531 | 12648253 | Malaise | |
| 126482531 | 12648253 | Micturition urgency | |
| 126482531 | 12648253 | Mobility decreased | |
| 126482531 | 12648253 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |